Written by cpm
Download PDF When the decision was made by BASF to bring a new triazole fungicide to market, an entirely new approach was needed to ensure it passed through the EU’s difficult approvals process. CPM tells the story. With Revysol we put the cart before the horse. By Tom Allen-Stevens They say necessity is the mother of innovation and you could argue it’s never been more necessary to bring new fungicide chemistry to growers. But perhaps the true innovation behind Revysol, the first new azole to reach the UK market for 15 years, has been the approach BASF has taken in the face of the tough EU regulatory regime. “With Revysol we put the cart before the horse,” notes UK and Ireland head of technical management Rob Gladwin. “The EU’s aversion to conventional crop protection is a major challenge for the industry, growers and eventually for consumers. Right from the start, research teams looked specifically for chemistry that does not harm mammals, recalls Rob Gladwin. “For the azoles there is the backdrop of concerns over endocrine disruption, so we addressed this head on – right from the start, our research teams looked not just to target enzymes in the fungal pathogens,…
The post Innovation Insight – Mission impossible? appeared first on cpm magazine.
Continue reading on CPM website...
If you are enjoying what you read then why not considering subscribing:
